Dr. Alex F. Herrera
Claim this profileCity of Hope Medical Center
About Alex F. Herrera
Education:
- Graduated Summa Cum Laude with an undergraduate degree from Princeton University, focusing on pre-med studies.
- Earned a Medical Degree from Harvard Medical School.
Experience:
- Completed an Internal Medicine Residency at Brigham and Women's Hospital.
- Undertook a Hematology/Oncology Fellowship at Dana-Farber Cancer Institute.
- Specializes in immunotherapy and hematopoietic stem cell transplantation with a focus on lymphoma, particularly Hodgkin lymphoma, at City of Hope Medical Center.
- Published significant research, including a lead-authored paper in The New England Journal of Medicine.
Area of expertise
Hodgkin's Lymphoma
Alex F. Herrera has run 9 trials for Hodgkin's Lymphoma. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Alex F. Herrera has run 8 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
City Of Hope Medical Center
City Of Hope Comprehensive Cancer Center
Clinical Trials Alex F. Herrera is currently running
Immunotherapy
for Hodgkin's Lymphoma
This trial is testing a new treatment called mosunetuzumab against the usual treatment, rituximab, for patients with a type of cancer called NLPHL. Both treatments help the immune system find and kill cancer cells by targeting a specific protein on these cells. The goal is to see if mosunetuzumab can improve survival better than rituximab.
Recruiting
1 award
Phase 2
Brentuximab Vedotin + Nivolumab
for Hodgkin's Lymphoma
This phase II trial investigates how well brentuximab vedotin and nivolumab work in treating patients with classical Hodgkin lymphoma that has come back after initial treatment (relapsed) or has not responded to initial treatment (refractory). Brentuximab vedotin is a monoclonal antibody, brentuximab, linked to a toxic agent called vedotin. Brentuximab attaches to CD30 positive cancer cells in a targeted way and delivers vedotin to kill them. Nivolumab is an antibody that enhances the immune system to better fight Hodgkin lymphoma cells. Giving brentuximab vedotin and nivolumab may be able to defer stem cell transplant treatment and spare the considerable cost and toxicity on transplantation.
Recruiting
1 award
Phase 2
24 criteria
More about Alex F. Herrera
Clinical Trial Related
6 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Alex F. Herrera has experience with
- Nivolumab
- Brentuximab Vedotin
- Etoposide
- Rituximab
- Cyclophosphamide
- Doxorubicin Hydrochloride
Breakdown of trials Alex F. Herrera has run
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Central Nervous System Hodgkin Lymphoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alex F. Herrera specialize in?
Alex F. Herrera focuses on Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Hodgkin's Lymphoma has involved Stage IV patients, or patients who are Stage I.
Is Alex F. Herrera currently recruiting for clinical trials?
Yes, Alex F. Herrera is currently recruiting for 6 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Alex F. Herrera has studied deeply?
Yes, Alex F. Herrera has studied treatments such as Nivolumab, Brentuximab Vedotin, Etoposide.
What is the best way to schedule an appointment with Alex F. Herrera?
Apply for one of the trials that Alex F. Herrera is conducting.
What is the office address of Alex F. Herrera?
The office of Alex F. Herrera is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.